Document is current
Any future updates will be listed below
-
Authors
Balle, Camilla Mains https://orcid.org/0000-0001-7890-8201
Nørgaard, Signe M. https://orcid.org/0000-0001-8094-9934
Baggesgaard, Christine M. B.
Valsted, Line B.
Viuff, Mette H.
Naeraa, Rune W.
Dueholm, Margit
Jakobsen, Mette-Cathrine R.
Bache, Iben
Kristensen, Stine Gry
Fischer, Margit B.
Hansen, Dorte https://orcid.org/0000-0002-6598-9740
Main, Katharina M.
Pedersen, Anette T.
Hagen, Casper P. https://orcid.org/0000-0002-0250-8049
Gravholt, Claus H. https://orcid.org/0000-0001-5924-1720
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF220C007962)
Frimodt-Heineke Fonden (Frimodt-Heineke Fonden)
Grosserer L. F. Foghts Fond (Grosserer L. F. Foghts Fond)
Den A. P. Møllerske Støttefond (Den A. P. Møllerske Støttefond)
Dagmar Marshalls Fond (Dagmar Marshalls Fond)
- License Information
-
More Information
Article History
Received: 10 August 2025
Accepted: 13 October 2025
First Online: 17 November 2025
Declarations
:
: The study protocol has been approved by the Scientific Ethics Committees for the Central Denmark Region (1-10-72-322-21). Written informed consent is obtained from all legal guardians. Girls aged ≥ 15 years must provide their own written consent in addition to that of their parents. Upon reaching the age of 18, participants will be asked to reconsent. All clinical investigations are conducted in accordance with the principles of the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
